Quarterly Call Option Transactions in Revance Therapeutics, Inc. (RVNC)
This table provides information about the institutional ownership of Revance Therapeutics, Inc. (RVNC) during . The information is specifically focused on institutions that hold call options of Revance Therapeutics, Inc..
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 10,700 | 27,990 | 38,690 | 51,200 | 0 | 51,200 | -12,510 | |
| Q4 2021 | 78,600 | 211,500 | 290,100 | 11,000 | 0 | 11,000 | 279,100 | |
| Q1 2022 | 605,200 | 47,800 | 653,000 | 8,100 | 34,000 | 42,100 | 610,900 | |
| Q2 2022 | 16,300 | 124,600 | 140,900 | 237,900 | 47,800 | 285,700 | -144,800 | |
| Q3 2022 | 5,971,300 | 1,191,100 | 7,162,400 | 4,700 | 0 | 4,700 | 7,157,700 | |
| Q4 2022 | 1,542,000 | 436,300 | 1,978,300 | 2,186,200 | 0 | 2,186,200 | -207,900 | |
| Q1 2023 | 44,800 | 298,200 | 343,000 | 917,600 | 0 | 917,600 | -574,600 | |
| Q2 2023 | 10,100 | 37,300 | 47,400 | 347,100 | 0 | 347,100 | -299,700 | |
| Q3 2023 | 54,900 | 162,800 | 217,700 | 285,300 | 0 | 285,300 | -67,600 | |
| Q4 2023 | 616,300 | 55,000 | 671,300 | 7,900 | 0 | 7,900 | 663,400 | |
| Q1 2024 | 88,700 | 30,000 | 118,700 | 669,000 | 0 | 669,000 | -550,300 | |
| Q2 2024 | 2,700 | 120,000 | 122,700 | 174,700 | 0 | 174,700 | -52,000 | |
| Q3 2024 | 117,000 | 295,500 | 412,500 | 33,100 | 0 | 33,100 | 379,400 | |